What client population is at risk of developing tardive dyskinesia?
Clients who have received long-term neuroleptic treatment.
Clients who have discontinued their neuroleptic treatment.
Clients who have experienced neuroleptic malignant syndrome (NMS).
Clients who have received monoamine oxidase inhibitors (MAOIS).
The Correct Answer is A
A) Correct. Tardive dyskinesia is a side effect of long-term neuroleptic (antipsychotic) treatment. It is characterized by involuntary, repetitive movements, particularly of the face and tongue. This condition is more commonly seen in clients who have been on neuroleptics for extended periods.
B) Incorrect. Discontinuing neuroleptic treatment may lead to withdrawal symptoms or symptom recurrence, but it does not directly increase the risk of developing tardive dyskinesia.
C) Incorrect. Neuroleptic malignant syndrome (NMS) is a different side effect associated with neuroleptic medications, characterized by hyperthermia, autonomic dysregulation, altered mental status, and generalized muscle rigidity.
D) Incorrect. Monoamine oxidase inhibitors (MAOIs) are a different class of medications and are not associated with the development of tardive dyskinesia.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A) Correct. Schizoaffective disorder is characterized by a combination of symptoms of schizophrenia (such as delusions and hallucinations) and mood disorders (such as depression or mania).
B) Incorrect. Waxy flexibility and catatonic excitement are more commonly associated with catatonic schizophrenia, not schizoaffective disorder.
C) Incorrect. Bizarre mannerisms and hostility may be seen in various psychiatric disorders but are not specific to schizoaffective disorder.
D) Incorrect. While agitation and ideas of reference can occur in schizoaffective disorder, they are not the defining features of this diagnosis.
Correct Answer is D
Explanation
A. Increasing aggression may be an indication for a PRN medication, but benztropine specifically targets extrapyramidal symptoms (EPS).
B. Elevated blood pressure is not a direct indication for benztropine; it is used to address EPS.
C. Complaints of dizziness may not be directly related to EPS, which is the target of benztropine.
D. Benztropine is an anticholinergic medication used to manage extrapyramidal symptoms (EPS) associated with antipsychotic medications like haloperidol.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
